4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000007
Sr. VP & CSO sold 33,981 shares at an average $89.52 ($3,041,910)
- Sr. VP & CSO gave up 6,993 shares (to pay taxes)
- Sr. VP & CSO acquired 25,977 shares (option exercise)
- Sr. VP & CSO acquired 15,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Or Yat Sun · Sr. VP & CSO
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-11 | Exercise or conversion : show line 1 in the form | +10,249 | $11.77 | $120,631 | 320,169 | D |
| 2019-02-11 | Exercise or conversion : show line 2 in the form | +6,956 | $14.00 | $97,384 | 327,125 | D |
| 2019-02-11 | Exercise or conversion : show line 3 in the form | +8,772 | $14.18 | $124,387 | 335,897 | D |
| 2019-02-11 | Sale : show line 4 in the form | −5,835 | $88.66 | $517,321 | 330,062 | D |
| 2019-02-11 | Sale : show line 5 in the form | −18,971 | $89.50 | $1,697,878 | 311,091 | D |
| 2019-02-11 | Sale : show line 6 in the form | −2,707 | $90.11 | $243,936 | 308,384 | D |
| 2019-02-11 | Sale : show line 7 in the form | −171 | $91.24 | $15,602 | 308,213 | D |
| 2019-02-12 | Sale : show line 8 in the form | −6,297 | $90.07 | $567,173 | 301,916 | D |
| Open-market sales · 33,981 sh · avg $89.52 · $3,041,910 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-02-11 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −10,249 | $11.77 | 2022-06-20 | 10,249 | 3,672 | D |
| 2019-02-11 | Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) | −6,956 | $14.00 | 2023-03-20 | 6,956 | 13,926 | D |
| 2019-02-11 | Exercise or conversion : show line 14 in the form Stock Option (Right to Buy) | −8,772 | $14.18 | 2022-12-26 | 8,772 | 5,149 | D |
Loading xslF345X03/edgar.xml…